Results 191 to 200 of about 8,511,971 (350)
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Bridging the gap: a review of the factors contributing to differences in vaccination coverage among rural and urban adults. [PDF]
Granade C +5 more
europepmc +1 more source
Small Business Survival Index Traction And Movement In Rankings Of States (2000-2013)
P. K. Shukla, Monica Shukla
openalex +2 more sources
X-ray Crystal Structures of the Estrogen-related Receptor-γ Ligand Binding Domain in Three Functional States Reveal the Molecular Basis of Small Molecule Regulation [PDF]
Liping Wang +8 more
openalex +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Abdominal tuberculosis presenting as a massive lower GI bleed in a cerebral palsy patient-a case report. [PDF]
Kravets AM +4 more
europepmc +1 more source
Learning from Small States for Post-2015 Educational and International Development
Michael Crossley, Terra Sprague
openalex +2 more sources
Exploring Firm-Level Innovation and Productivity in Developing Countries: The Perspective of Caribbean Small States [PDF]
Gustavo Crespi +14 more
openalex +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source

